Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Take heart, it’s all good news

31.03.2005


New evidence uncovered by researchers in Tayside and Bristol has shown wider benefits of cholesterol lowering drugs for large sections of the public, including women and the elderly.

Researchers have told us for years that cholesterol lowering drugs that lower blood fat levels provide large benefits to those who participated in clinical trails. However, the effects of these drugs were only really applicable to the sorts of carefully selected patients who actually participated in those trials.

The new evidence now available from a combined Tayside and Bristol research project, published this week in the British Medical Journal, shows that these drugs provide benefits of at least an equal level of benefit to patients groups who were excluded from the clinical trial - the old, the very old, women and those who are unfortunate enough to suffer from a number of other pre-existing diseases. This is really good news for those patients because it has often been found that when taken in general use rather than in clinical trials, medicines do not seem to work as well. This can be because the people in the trials have been selected to be those that will benefit most or those that will have the fewest side effects.



Professor Tom MacDonald, of the University of Dundee, the lead author of the research said “The results of this study are very important as we know now that all patients get similar benefits to those who were in the original studies. It is also good news for the research technique of studying routinely collected data (in an anonymous way of course) of many NHS patients and importantly using quality NHS data as well as being able to bring together data from a range of NHS sources. Such research has important implications in ensuring a good risk/benefit ratio for all medicines.”

The study looked at the data of nearly 5000 patients who were discharged from hospital following a heart attack over an 8 year period. The researchers checked to see the level of cardiovascular outcomes or deaths occurring in these patients and whether they had been treated with statin (the name for a particular type of drug class that lowers cholesterol). Those treated with statins had lower rates of cardiovascular outcomes and death compared to those not treated and the level of benefit were similar across all patient groups. Additionally this research study included a far greater proportion of women and showed they also had good results.

This research is part of an on-going series of projects being undertaken by university researchers in conjunction with the NHS in Tayside that uses advanced methods to develop anonymous clinical information. This ensures that the researchers can make the maximum use of such information whilst ensuring confidentiality. Such research helps to ensure that the treatments available on the NHS have the right balance of benefit and risk.

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk/pressreleases/prmar05/heart.html

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>